Overview A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea Status: Completed Trial end date: 2008-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea. Phase: Phase 2 Details Lead Sponsor: Dow Pharmaceutical Sciences